SGLT2 Inhibitors for Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Time to Deliver Implementation

By sjmartinez • September 13, 2022

Greene SJ, Fonarow GC, Butler J. SGLT2 Inhibitors for Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Time to Deliver Implementation. Eur J Heart Fail. 2022 Sep 13. doi: 10.1002/ejhf.2688. Epub ahead of print. PMID: 36097872.

Tags: Cardiology/Epi, Publications

Related Posts

Intensive Versus Standard Blood Pressure Control After Endovascular Thrombectomy in Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials

Hashmi TM, Ahmed M, Ashraf H, Shakir M, Bhatti IA, Ahmed F, Alareed A, Hasan A, Ahmed R, Rafiq S, Aized MT, Fonarow GC, Hassan[...]

p21+TREM2+ senescent macrophages fuel inflammaging and metabolic dysfunction-associated steatotic liver disease

Salladay-Perez IA, Avila I, Estrada L, Alexandru AC, Ponce C, Dhingra A, Torres G, Deng CY, Hegde R, Gensheimer J, Kale A, Heckenbach I, Hui[...]

InChagas: Feasibility Study of a Tele-Education Strategy to Promote Early Identification and Care of People Living with Chagas Cardiomyopathy in an Endemic Community in Argentina

Gulayin PE, Gimenez C, Chirino D, Nascimento B, Salvá L, Cavallo AS, Gutierrez L, Blanco L, Flores LPC, Espina E, Shakil SS, Vervoort D, Davis[...]